Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alia Ahmad has a total of 135 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Patterns of Pediatric Cancer Care at a Tertiary Center in Pakistan: A Hospital‐Based Registry Analysis

    by Alia Ahmad, Ryan R. Lion, Masood Sadiq, Muhammad Mohsin, Mahwish Faizan, Montserrat Hernandez‐Garcia, Nickhill Bhakta

    Background: Childhood cancer outcomes remain poor in many low‐ and middle‐income countries, in part due to delays in diagnosis, incomplete staging, and health system constraints. However, detailed site‐level descriptions of pediatric oncology care pathways in South Asia remain limited. Methods: We conducted a descriptive observational analysis using routinely collected data from a hospital‐based pediatric cancer registry at the Children's Hospital Lahore. Children and adolescents (<18 years) registered between July 2021 and April 2026 were included. We summarized demographics, cancer type distribution, diagnostic confirmation methods, treatment intent, care timelines from symptom onset to treatment initiation, and documented mortality outcomes. Results: A total of 7583 children were registered. Median age at diagnosis was 5 years, and 61.2% were male. Leukemias and lymphomas accounted for 50.2% and 12.8% of confirmed diagnoses, respectively, with acute lymphoblastic leukemia the most common diagnosis (41.4%). Microscopic verification was achieved in over 90% of cases. Median time from symptom onset to first medical assessment was 25 days, and median time from diagnosis to treatment initiation was 2 days. Curative‐intent treatment was initiated in over 80% of patients. Among patients with available follow‐up data, 1437 deaths were documented, with longitudinal outcome data varying in maturity as follow‐up accumulated through subsequent registry forms. Conclusions: This large registry‐based descriptive analysis provides a comprehensive overview of pediatric cancer presentation, diagnostic pathways, and treatment timelines at a major referral center in Pakistan. Findings demonstrated strengths in diagnostic confirmation and rapid treatment initiation following diagnosis, while identifying gaps including delays before first medical assessment and a substantial burden of infection‐related mortality. This work demonstrates the feasibility of implementing large‐scale hospital‐based cancer registries in resource‐constrained settings to support quality improvement and health system strengthening.

  • Open Access

    Role of Granulocyte-Colony Stimulating Factor (G-CSF) in Febrile Neutropenia among Pediatric Cancer Patients in Resource-Limited Settings

    by Alia Ahmad, Fauzia Shafi Khan, Mahvish Hussain, Shakila Mushtaq, Irsa Iqbal, Sana Gull

    Background: Chemotherapy-induced Febrile neutropenia (FN) is a potentially catastrophic complication in childhood cancer, requiring urgent management and hospitalization, with a heightened risk of mortality. Granulocyte-colony stimulating factors (G-CSFs) are used both prophylactically to decrease FN episodes and therapeutically during febrile neutropenia. However, evidence supporting their role in resource-limited settings remains scarce. Objectives: To evaluate the effect of granulocyte colony-stimulating factor on hospital stay duration, treatment cost, and mortality among children suffering from febrile neutropenia. Methodology: This prospective cohort study enrolled 250 children with chemotherapy-induced FN at the Children’s Hospital Lahore (CHL) from September 2018 to December 2018. Patients received G-CSF (filgrastim, 10 mcg/kg/day for five days or until ANC >1000 for two consecutive days), primarily in the solid malignancy group. Clinical characteristics, neutrophil counts, hospital stay, treatment costs, and outcomes were recorded. Data were analyzed using SPSS 23. Results: G-CSF significantly decreased hospital stay (p = 0.048) and was administered more frequently in instances of severe neutropenia (ANC < 100x10³/µL in 82% of cases, p = 0.000). Mortality in the G-CSF group was 3%, though not statistically significant (p = 0.147). In clinical settings, G-CSF improved hematological recovery in solid malignancies and was cost-effective (p = 0.027). Conclusion: G-CSF demonstrated superior clinical efficacy compared to intravenous antibiotics alone by reducing hospitalization and neutropenia severity, without imposing a substantial cost burden. These findings support G-CSF as a desirable FN management strategy, even in low-resource pediatric oncology centers.

  • Open Access

    Primary central nervous system lymphoma in children: Insights from the three-year experience at the largest public-sector pediatric oncology center in Pakistan

    by Rahat- Ul- Ain, Fiza Ismail, Laeeq- Ur- Rehman, Rabia Qaiser, Alia Ahmad, Mahwish Faizan

    Objective: Primary CNS lymphoma (PCNSL) in children is a rare disease, and this study aimed to document the experience of dealing with this in our geographical and resource settings. Methodology: It was an ambidirectional cohort study conducted at the Department of Pediatric Hematology/Oncology and the Department of Pediatric Neurosurgery at the University of Child Health Sciences, The Children’s Hospital Lahore, Pakistan from March 2024 to December 2024. This study included seven suspected and confirmed cases of PCNSL in children under the age of 16 years who presented to a public-sector specialized center in Pakistan over the three-year study period. Results: A total of seven cases of suspected PCNSL were included in the study. The median age at presentation was eight years, with a female-to-male ratio of 2.5:1. Most commonly presenting with a focal neurological deficit, with a median duration of symptoms of 12 weeks, and a median Lansky performance score of 50. Only 57% (04) of patients underwent surgical resection followed by adjuvant chemotherapy. Overall, 57% (03) of patients died, 29% (02) were lost to follow-up, and only 14% (01) are under treatment. Conclusion: PCNSL in children is equally rare in our part of the world, but has a dismal survival rate. Timely surgical intervention, improved supportive care, and a reduction in treatment abandonment might improve the prognosis.


  • Clinical Stage of Retinoblastoma Based on Presenting Signs of 4578 Patients from 121 Countries

    by Ryan T. Yanagihara, Jamie S.K. Takayesu, Erin E. Crotty, Xunda Ji, Yihua Zou, Sadia Sultana, Riffat Rashid, Sadik Taju Sherief, Nathalie Cassoux, Juan L. Garcia Leon, et al.


  • Using Research Capacity Enhancement to Develop and Implement National Standard-of-Care Treatment Protocols in Pakistan

    by Mohiba A. Khowaja, Alia Ahmad, Sadaf Altaf, Sadia Anwar, Mahwish Faizan, Tariq Ghafoor, Uzma Imam, Zulfiqar Ali Rana, Rabia Wali, Nuzhat Yasmeen, et al.

    PURPOSE: Utilization of clinical research methodology as a means for improvement in pediatric cancer outcomes is well established. Toward achievement of its WHO-Global Initiative for Childhood Cancer (GICC) goals in Pakistan, the Pakistan Society of Pediatric Oncology (PSPO) has used this methodology to develop and implement standard-of-care (SOC) protocols nationally, with centralized research and data management support. This article describes the strategy for its implementation and provides a foundation for future advancements in cancer care in Pakistan. METHODS: The following steps were used to achieve the objectives: Central Support: A central PSPO office was established with minimal required staffing for provision of support to clinicians for protocol development and implementation and housing data and documents. Clinical protocols: multi-institutional teams, supported by central staff, developed SOC protocols on the basis of international evidence and local experience for six GICC target diagnoses. These went through an iterative consultation and revision process and were finally approved by the PSPO Board. Protocol implementation: case report forms and databases were developed using RedCap software and tested for functionality. Education and training were provided to institutional principal investigators and data entry personnel on the disease, protocol, use of RedCap, and data entry. Data quality maintenance: a system was established for ongoing data quality maintenance through central support and augmented by virtual and on-site audits. Where required, targeted training was provided. Interim analyses are being performed to assess data quality and early outcomes. RESULTS: Development and implementation of protocols occurred over 26 months. Each protocol is currently active in at least seven centers. Almost 2,000 patients have been enrolled. Interim analysis of ALL data shows 85% data accuracy. CONCLUSION: Research infrastructure and capacity building for implementation of multi-institutional treatment protocols in low- and middle-income countries with modest resources is feasible.


  • Treatment Outcomes and Definition Inconsistencies in High-Risk Unilateral Retinoblastoma

    by Mattan Arazi, Alona Baum, Sandro Casavilca-Zambrano, Sandra Alarcon-Leon, Rosdali Diaz-Coronado, Alia Ahmad, Asma Mushtaq, Mahvish Hussain, Tatiana Ushakova, Serov Yuri, et al.


  • Open Access

    Barriers and Facilitators of Quality Family-Centered Communication in Pakistan

    by Dylan Graetz, Alia Ahmad, Muhammad Rafie Raza, Ambreen Hameed, Asma Naheed, Atoofa Najmi, Afia Tul Quanita, Shabnam Munir, Gia Ferrara, Courtney Staples, et al.

    PURPOSE: Communication is a fundamental aspect of patient- and family-centered care. Unfortunately, there is a dearth of evidence regarding pediatric cancer communication in low- and middle-income countries, where over 90% of all children with childhood cancer live. The purpose of this study was to explore barriers and facilitators of quality communication within two pediatric cancer centers in Pakistan. METHODS: Semistructured interviews were conducted with 20 multidisciplinary pediatric cancer clinicians and 18 caregivers of children with cancer at Children's Hospital of Lahore and Indus Hospital in Karachi, Pakistan. Interviews were conducted in English or Urdu, audio-recorded, transcribed, and translated to English. Two researchers coded each transcript using an inductively derived codebook. Thematic content analysis focused on barriers and facilitators of high-quality communication. RESULTS: Pakistani clinicians and caregivers identified factors that affected the quality of patient-centered cancer communication. These included structural factors including setting, available interpreters, documentation, patient volume, teamwork, and financial support. Clinician-level communication barriers and facilitators included communication training, clinician distress/boundaries, and the ability to have recurrent conversations. Patient or family characteristics affecting communication included education, income status, primary language, and geography; the child's specific disease type; and relational elements such as social support, empowerment, and split decision makers. Participants identified existing or potential interventions related to each factor. CONCLUSION: Multilevel factors serve as either barriers or facilitators for pediatric cancer communication in Pakistan. Identification of these elements of communication is an essential step toward interventions aimed at improving patient- and family-centered care in resource limited settings.


  • Open Access

    The Effects of Breastfeeding on Retinoblastoma Development: Results from an International Multicenter Retinoblastoma Survey

    by Jasmeen K. Randhawa, Mary E. Kim, Ashley Polski, Mark W. Reid, Kristen Mascarenhas, Brianne Brown, Ido Didi Fabian, Swathi Kaliki, Andrew W. Stacey, Elizabeth Burner, et al.

    The protective effects of breastfeeding on various childhood malignancies have been established but an association has not yet been determined for retinoblastoma (RB). We aimed to further investigate the role of breastfeeding in the severity of nonhereditary RB development, assessing relationship to (1) age at diagnosis, (2) ocular prognosis, measured by International Intraocular RB Classification (IIRC) or Intraocular Classification of RB (ICRB) group and success of eye salvage, and (3) extraocular involvement. Analyses were performed on a global dataset subgroup of 344 RB patients whose legal guardian(s) consented to answer a neonatal questionnaire. Patients with undetermined or mixed feeding history, family history of RB, or sporadic bilateral RB were excluded. There was no statistically significant difference between breastfed and formula-fed groups in (1) age at diagnosis (p = 0.20), (2) ocular prognosis measures of IIRC/ICRB group (p = 0.62) and success of eye salvage (p = 0.16), or (3) extraocular involvement shown by International Retinoblastoma Staging System (IRSS) at presentation (p = 0.74), lymph node involvement (p = 0.20), and distant metastases (p = 0.37). This study suggests that breastfeeding neither impacts the sporadic development nor is associated with a decrease in the severity of nonhereditary RB as measured by age at diagnosis, stage of disease, ocular prognosis, and extraocular spread. A further exploration into the impact of diet on children who develop RB is warranted.


  • Open Access

    Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries

    by Swathi Kaliki, Xunda Ji, Yihua Zou, Riffat Rashid, Sadia Sultana, Sadik Taju Sherief, Nathalie Cassoux, Rosdali Y. Diaz Coronado, Juan Luis Garcia Leon, Arturo Manuel Zapata López, et al.

    Background: The relationship between lag time and outcomes in retinoblastoma (RB) is unclear. In this study, we aimed to study the effect of lag time between onset of symptoms and diagnosis of retinoblastoma (RB) in countries based on their national-income and analyse its effect on the outcomes. Methods: We performed a prospective study of 692 patients from 11 RB centres in 10 countries from 1 January 2019 to 31 December 2019. Results: The following factors were significantly different among different countries based on national-income level: age at diagnosis of RB (p = 0.001), distance from home to nearest primary healthcare centre (p = 0.03) and mean lag time between detection of first symptom to visit to RB treatment centre (p = 0.0007). After adjusting for country income, increased lag time between onset of symptoms and diagnosis of RB was associated with higher chances of an advanced tumour at presentation (p < 0.001), higher chances of high-risk histopathology features (p = 0.003), regional lymph node metastasis (p < 0.001), systemic metastasis (p < 0.001) and death (p < 0.001). Conclusions: There is a significant difference in the lag time between onset of signs and symptoms and referral to an RB treatment centre among countries based on national income resulting in significant differences in the presenting features and clinical outcomes.